UNSPSC 51294408: Oxypertine

This classification denotes a dopamine antagonist with the molecular formula C23H29N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5JGL4G25R7, chemically known as 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)indole but generally known as oxypertine, which bears US NIH Compound Identifier 4640. European Medicines Agency schedules Oxypertine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09571MIG.

UNSPSC 51294408 Oxypertine is a Commodity code that does not match the scope of work actually being solicited under it in recent state and local procurements. The three most recent opportunities tagged to this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which are oxypertine, an antipsychotic medication with a narrow clinical application. The code shows little relevant recent activity; the mismatch between the UNSPSC designation and the actual pharmaceutical and harm-reduction products being procured suggests either a tagging error or that oxypertine procurement through state and local channels is not currently active.

The three recent opportunities span different procurement models and issuing bodies. Seminole County, Florida posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2026; the Texas Health and Human Services Commission issued an RFI on April 3, 2026, to explore direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (administered by the Minnesota Department of Administration's Office of State Procurement) posted an RFP on January 20, 2026, due March 26, 2026, for generic multi-source pharmaceuticals and OTC products through authorized wholesalers for participating state and local government facilities, including Oregon. These solicitations reflect procurement activity in Florida, Texas, and Minnesota, but none address oxypertine specifically. Business development professionals should verify whether the code assignment is correct before pursuing activity under this Commodity code.